RUSSELL FRANK CO/ - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 89 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2016$67,000
+109.4%
70,192
+473.8%
0.00%
Q3 2013$32,000
+68.4%
12,232
+71.3%
0.00%
Q2 2013$19,0007,1420.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2013
NameSharesValueWeighting ↓
Sowell Financial Services LLC 506,634$190,0000.05%
Harel Insurance Investments & Financial Services Ltd. 780,000$328,0000.02%
LifePlan Financial Group, Inc 28,810$12,0000.01%
AURORA FINANCIAL ADVISORS, LLC 32,500$11,0000.01%
WEDBUSH SECURITIES INC 169,000$61,0000.01%
Greenwich Wealth Management LLC 60,066$22,0000.00%
Jacobi Capital Management LLC 20,130$8,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 649,880$233,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 436,272$156,0000.00%
McCollum Christoferson Group LLC 17,155$6,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders